1
TÍTULO: Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
AUTORES: Gourgou-Bourgade, S; Cameron, D; Poortmans, P; Asselain, B; Azria, D; Cardoso, F; A'Hern, R; Bliss, J; Bogaerts, J; Bonnefoi, H; Brain, E; M.J Cardoso; Chibaudel, B; Coleman, R; Cufer, T; Dal Lago, L; Dalenc, F; De Azambuja, E; Debled, M; Delaloge, S; Filleron, T; Gligorov, J; Gutowski, M; Jacot, W; Kirkove, C; MacGrogan, G; Michiels, S; Negreiros, I; B.V Offersen; Penault Llorca, F; Pruneri, G; Roche, H; N.S Russell; Schmitt, F ; Servent, V; Thürlimann, B; Untch, M; J.A van der Hage; van Tienhoven, G; Wildiers, H; Yarnold, J; Bonnetain, F; Mathoulin-Pélissier, S; Bellera, C; T.S Dabakuyo-Yonli; ...Mais
PUBLICAÇÃO: 2015, FONTE: Annals of Oncology, VOLUME: 26, NÚMERO: 12
INDEXADO EM: CrossRef: 35